SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-22-014376
Filing Date
2022-05-13
Accepted
2022-05-13 17:08:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 vlon424b5prospectussupplem.htm 424B5 409973
2 vallonpharmalogo1a1a.jpg GRAPHIC 52277
3 vallonpharmalogo1a2a.jpg GRAPHIC 28850
4 vallonpharmalogo1aa.jpg GRAPHIC 28865
  Complete submission text file 0001628280-22-014376.txt   562914
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264488 | Film No.: 22923898
SIC: 2834 Pharmaceutical Preparations